Literature DB >> 10195328

In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland.

G P Liney1, L W Turnbull, A J Knowles.   

Abstract

The quantitation of in vivo 1H MR spectroscopy and dynamic contrast enhanced MR imaging is described for patients with histologically confirmed prostate adenocarcinoma and benign prostatic hypertrophy (BPH). Results are presented which suggest that combined use of these techniques may be helpful in improving the characterization of prostate pathologies and ultimately increase the staging accuracy of magnetic resonance.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10195328     DOI： 10.1002/(sici)1099-1492(199902)12:1<39::aid-nbm543>3.0.co;2-1

Source DB:  PubMed          Journal:  NMR Biomed        ISSN： 0952-3480            Impact factor:   4.044


  8 in total

1.  Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma?

Authors:  R H Oyen
Journal:  Eur Radiol       Date:  2003-05       Impact factor: 5.315

Review 2.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

Review 3.  Multiparametric magnetic resonance imaging in prostate cancer: present and future.

Authors:  John Kurhanewicz; Daniel Vigneron; Peter Carroll; Fergus Coakley
Journal:  Curr Opin Urol       Date:  2008-01       Impact factor: 2.309

4.  Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer.

Authors:  Hyeon-Man Baek; Hon J Yu; Jeon-Hor Chen; Orhan Nalcioglu; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2007-12-03       Impact factor: 2.546

5.  Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.

Authors:  M Carlani; S Mancino; E Bonanno; E Finazzi Agrò; G Simonetti
Journal:  Radiol Med       Date:  2008-05-20       Impact factor: 3.469

Review 6.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

7.  Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues.

Authors:  Susan Moyher Noworolski; Daniel B Vigneron; Albert P Chen; John Kurhanewicz
Journal:  Magn Reson Imaging       Date:  2008-05-27       Impact factor: 2.546

Review 8.  Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective.

Authors:  Naranamangalam R Jagannathan; Virendra Kumar; Rajeev Kumar; Sanjay Thulkar
Journal:  MAGMA       Date:  2008-07-17       Impact factor: 2.310
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.